Pregnancy

What is the Best Scar Removal Cream for C-section?

The Best Scar Removal Cream for C-Section is Scar Protocol. SEATTLE, WA / ACCESS Newswire / December 19, 2025 /…

4 weeks ago

What is the Best Scar Removal Cream for C-section?

The Best Scar Removal Cream for C-Section is Scar Protocol. SEATTLE, WA / ACCESS Newswire / December 19, 2025 /…

4 weeks ago

Vitalis Ventures Announces $15 Million Strategic Funding for Drive Health to Accelerate Avery, the Clinical Workflow AI

Built on Google Cloud infrastructure, Drive Health is expanding Avery's clinical workflow and operational capabilities, building toward broader health system…

4 weeks ago

Festive drinking and hormones: Clue shares science-backed guidance for Christmas

LONDON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- With office parties, cocktails with friends and end-of-year celebrations in full swing, many…

4 weeks ago

Dyna AI to Streamline Point-of-Care Decisions with Integrated Dosing and Medication Safety Information

DynaMedex expansion will deliver an integrated AI workflow that combines expert clinician-reviewed evidence with authoritative medication intelligence in a single…

4 weeks ago

60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026

6-month commercial pilot demonstrated increasing demand among prescribersExpansion plan includes doubling the number of sales reps, a new GoodRx partnership,…

1 month ago

Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025

SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP)…

1 month ago

SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium

U.S. Losartan market totals $245M annually with 71M prescriptions  COMMACK, NY, Dec. 10, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC.…

1 month ago

SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium

U.S. Losartan market totals $245M annually with 71M prescriptions  COMMACK, NY, Dec. 10, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC.…

1 month ago